Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
249707
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/06/373
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
FDA ORPHAN DRUG |
90895
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
FDA ORPHAN DRUG |
91995
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
FDA ORPHAN DRUG |
93695
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
INCRELAX (AUTHORIZED: LARON SYNDROME)
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
FDA ORPHAN DRUG |
59191
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
FDA ORPHAN DRUG |
89795
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
FDA ORPHAN DRUG |
128999
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
WHO-ATC |
H01AC03
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
DSLD |
1469 (Number of products:4)
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
DSLD |
1772 (Number of products:8)
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
LOINC |
12252-3
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
FDA ORPHAN DRUG |
871322
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
WHO-VATC |
QH01AC03
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
NCI_THESAURUS |
C835
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
FDA ORPHAN DRUG |
856421
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
||
|
FDA ORPHAN DRUG |
491915
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4971
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
7GR9I2683O
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
m7114
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | Merck Index | ||
|
P05019
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
DTXSID7041049
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
7GR9I2683O
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
100000085465
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
SUB08672MIG
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
C2262
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
6372
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
CHEMBL1201716
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
5009
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
MECASERMIN
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
67763-96-6
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
GENERIC (FAMILY) | |||
|
68562-41-4
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
C065700
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
DB01277
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
HH-78
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | |||
|
m6299
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | Merck Index | ||
|
274403
Created by
admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
|
PRIMARY | RxNorm |
ACTIVE MOIETY